
Sosei Heptares has announced that it has dosed the first patient in its phase 1 trial assessing a novel EP4 …

Transgene and BioInvent have announced that the first patient has been treated in the phase 1 part B clinical trial …
Boyds expands Regulatory Affairs team to support growing demand
Sterling doubles ADC manufacturing capacity at Welsh facility
Femtosecond laser cuts lung tumour margin assessment time
Blood sensor detects Parkinson’s-associated proteins in 40 minutes

